A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans
HIV/AIDS
About this trial
This is an interventional supportive care trial for HIV/AIDS focused on measuring Adherence, Antiretroviral treatment, Black/ AfricanAmerican
Eligibility Criteria
Inclusion Criteria:
- HIV-positive
- 18 years of age or older
- Self-identified as African American/Black
- Been prescribed antiretroviral therapy (ART) in the past 12 months
- Self-reported adherence problems (i.e. missed at least 1 ART dose in the past month) and/or detectable viral load
- Willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.
Exclusion Criteria:
- HIV-negative
- 17 years of age or younger
- Not self-identified as African American/Black, not on antiretroviral therapy (ART) or not prescribed ART therapy in the last than 12 months
- No self-reported adherence problems and/or no detectable viral load
- Not willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.
Sites / Locations
- AIDS Project Los Angeles
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Rise - Treatment Education
Control - No Treatment Education
Rise consists of a one-month intensive intervention (with three core 60-minute counseling sessions at weeks 1, 2, and 4) followed by two booster sessions (at weeks 12 and 20). If participants show nonadherence during booster sessions, they are offered up to four additional booster sessions (i.e., extra booster sessions if <85% of prescribed doses were taken in the past month). Thus, participants receive three core sessions in the first month, followed by 2-6 booster sessions over the next four months.
The Usual Care control group will only receive standard of care through their HIV clinics.